Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/13/24
End: 11/22/24
Due: 11/22/25
Phase: N/A
Priority: Normal
Start: 10/31/18
End: 01/31/21
Due: 01/31/22
Safety and Efficacy of a Sub-epitheilal Transform™ Corneal Allograft (TCA) for Presbyopia Correction
Phase: N/A
Priority: Normal
Start: 10/31/18
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 08/09/18
End: 12/31/21
Due: 12/31/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy of an Intrastromal Transform Corneal Allograft (TCA) for Presbyopia Correction - Long Term Follow-up | NCT06310252 | Allotex, Inc. | user2@example.com | None | 2024-02-13 | 2024-11-22 | 2025-11-22 | - | - | 2025-07-14 |
| Safety and Efficacy of the Transform™ Corneal Allograft for Hyperopia Correction | NCT03671096 | Allotex, Inc. | user2@example.com | None | 2018-10-31 | 2021-01-31 | 2022-01-31 | - | - | 2025-07-14 |
| Safety and Efficacy of a Sub-epitheilal Transform™ Corneal Allograft (TCA) for Presbyopia Correction | NCT03675438 | Allotex, Inc. | user2@example.com | None | 2018-10-31 | 2021-01-31 | 2022-01-31 | - | - | 2025-07-14 |
| Safety and Efficacy of an Intrastromal Transform™ Corneal Allograft (TCA) for Presbyopia Correction | NCT03671135 | Allotex, Inc. | user2@example.com | None | 2018-08-09 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |